0001493152-26-030079.txt : 20260625 0001493152-26-030079.hdr.sgml : 20260625 20260625134339 ACCESSION NUMBER: 0001493152-26-030079 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260625 DATE AS OF CHANGE: 20260625 EFFECTIVENESS DATE: 20260625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trails Edge Biotechnology Offshore Fund, LP CENTRAL INDEX KEY: 0002070384 ORGANIZATION NAME: EIN: 981835471 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-549855 FILM NUMBER: 261120275 BUSINESS ADDRESS: STREET 1: 3455 PEACHTREE ROAD NE STREET 2: 5TH FLOOR CITY: ATLANTA STATE: GA ZIP: 30326 BUSINESS PHONE: 917-657-2249 MAIL ADDRESS: STREET 1: 3455 PEACHTREE ROAD NE STREET 2: 5TH FLOOR CITY: ATLANTA STATE: GA ZIP: 30326 D/A 1 primary_doc.xml X0708 D/A LIVE 0002070384 Trails Edge Biotechnology Offshore Fund, LP 3445 PEACHTREE ROAD NE SUITE 900 ATLANTA GA GEORGIA 30326 770-600-9010 CAYMAN ISLANDS None None Other Cayman Islands Exempted LimitedPartnership true 2025 - Trails Edge Biotechnology Fund GP, LP 3445 Peachtree Road NE Suite 900 Atlanta GA GEORGIA 30326 Executive Officer General Partner - Trails Edge Capital Partners, LP 3445 Peachtree Road NE Suite 900 Atlanta GA GEORGIA 30326 Executive Officer Investment Manager Ortav Yehudai 3445 Peachtree Road NE Suite 900 Atlanta GA GEORGIA 30326 Executive Officer Matthew Diaz 3445 Peachtree Road NE Suite 900 Atlanta GA GEORGIA 30326 Executive Officer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001641172-25-016424 2025-07-01 true true false 0 Indefinite 292874003 Indefinite false 36 0 0 0 true The Investment Manager will receive a fee based on each limited partner's capital account balance and the General Partner may receive anincentive allocation as more fully set forth in the offering materials. false Trails Edge Biotechnology Offshore Fund, LP /s/ Matthew Diaz Matthew Diaz CFO/COO/CCO 2026-06-25